The Only Specialized Global Intellectual Property News Agency
A Member of Talal Abu-Ghazaleh Global

Noven Files Patent Infringement Lawsuit Against Mylan Technologies

23-Feb-2011 | Source : | Visits : 8387

MIAMI, FLORIDA - Noven Pharmaceuticals Inc. announced in a press release that it has filed a lawsuit in the US District Court for the Southern District of New York against Mylan Technologies Inc. ("Mylan") claiming infringement of certain Noven patents (the "Patents") by Mylan.

The lawsuit was filed as a result of an Abbreviated New Drug Application (ANDA) submission by Mylan seeking FDA approval to market and sell a generic version of Vivelle-Dot® (estradiol transdermal system) prior to the scheduled expiration of the Patents in 2014. The lawsuit reflects Noven’s commitment to vigorously defending its intellectual property rights against infringement.

Under the Hatch-Waxman Act, because Noven filed this patent infringement lawsuit within 45 days of receiving a Paragraph IV notification letter from Mylan, the FDA must refrain from approving Mylan’s ANDA for 30 months (until June 2013), or until a district court decision declaring that the Patents are invalid or not infringed, whichever occurs earlier.

Noven Pharmaceuticals Inc. is a specialty pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of prescription pharmaceutical products.


Related Articles